Loss-of-function of GABARAP drives tumor resistance to bortezomib-induced immunogenic cell death in multiple myeloma

被引：0
|
作者：
Gulla, Annamaria [1 ,2 ]
Morelli, Eugenio [1 ,2 ]
Samur, Mehmet K. [3 ]
Botta, Cirino [4 ]
Johnstone, Megan [3 ]
Bianchi, Giada [5 ]
Fulciniti, Mariateresa [1 ,2 ]
Yamamoto, Leona [3 ]
Prabhala, Rao [3 ]
Wen, Kenneth [3 ]
Richardson, Paul G. [3 ]
Tai, Yu-Tzu [1 ,2 ]
Chauhan, Dharminder [6 ]
Hideshima, Teru [3 ]
Munshi, Nikhil C. [1 ,2 ,7 ]
Anderson, Kenneth [1 ,2 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Annunziata Hosp Cosenza, Dept Oncol, Hematol Unit, Cosenza, Italy
[5] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[7] VA Boston Healthcare Syst, Boston, MA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-033
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 40 条
  • [1] Clinically relevant GABARAP deficiency abrogates bortezomib-induced immunogenic cell death in multiple myeloma
    Zhao, Liwei
    Shen, Zhe
    Kroemer, Guido
    Kepp, Oliver
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [2] Loss-of-Function of Gabarap Impairs Bortezomib-Induced Anti-Tumor Immunity in Multiple Myeloma: Clinical Application
    Gulla, Annamaria
    Morelli, Eugenio
    Samur, Mehmet Kemal
    Hideshima, Teru
    Bianchi, Giada
    Fulciniti, Mariateresa
    Prabhala, Rao
    Talluri, Srikanth
    Tai, Yu-Tzu
    Chauhan, Dharminder
    Carrasco, Ruben D.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2019, 134
  • [3] Mechanisms, biologic sequelae and clinical benefits of bortezomib-induced immunogenic cell death in multiple myeloma
    Gulla, Annamaria
    Morelli, Eugenio
    Samur, Mehmet
    Hideshima, Teru
    Bianchi, Giada
    Fulciniti, Mariateresa
    Rao, Prabhal
    Talluri, Srikanth
    Tai, Yu-Tzu
    Chauhan, Dharminder
    Carrasco, Ruben
    Munshi, Nikhil
    Anderson, Kenneth C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E162 - E162
  • [4] Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma
    Gulla, Annamaria
    Morelli, Eugenio
    Johnstone, Megan
    Turi, Marcello
    Samur, Mehmet K.
    Botta, Cirino
    Cifric, Selma
    Folino, Pietro
    Vinaixa, Delaney
    Barello, Francesca
    Clericuzio, Cole
    Favasuli, Vanessa Katia
    Maisano, Domenico
    Talluri, Srikanth
    Prabhala, Rao
    Bianchi, Giada
    Fulciniti, Mariateresa
    Wen, Kenneth
    Kurata, Keiji
    Liu, Jiye
    Penailillo, Johany
    Bragoni, Alberto
    Sapino, Anna
    Richardson, Paul G.
    Chauhan, Dharminder
    Carrasco, Ruben D.
    Hideshima, Teru
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2024, 143 (25) : 2612 - 2626
  • [5] Bortezomib-induced tumor lysis syndrome in multiple myeloma
    Sezer, Orhan
    Vesole, David H.
    Singhal, Seema
    Richardson, Paul
    Stadtmauer, Edward
    Jakob, Christian
    Boral, Anthony L.
    Esseltine, Dixie-Lee
    Mehta, Jayesh
    CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (03): : 233 - 235
  • [6] Bortezomib Induces Immunogenic cell Death in Multiple Myeloma
    Zitvogel, Laurence
    Kroemer, Guido
    BLOOD CANCER DISCOVERY, 2021, 2 (05): : 405 - 407
  • [7] Bortezomib-induced immunogenic cell death enhances immune response in melanoma
    Daignault, S. M.
    Ju, R.
    Spoerri, L.
    Stehbens, S. J.
    Hill, D. S.
    Gabrielli, B.
    Dolcetti, R.
    Haass, N. K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S143 - S143
  • [8] Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
    Francesco Piazza
    Sabrina Manni
    Laura Quotti Tubi
    Barbara Montini
    Laura Pavan
    Anna Colpo
    Marianna Gnoato
    Anna Cabrelle
    Fausto Adami
    Renato Zambello
    Livio Trentin
    Carmela Gurrieri
    Gianpietro Semenzato
    BMC Cancer, 10
  • [9] Bortezomib-Induced Proinflammatory Macrophages Contribute to Multiple Myeloma Cell Aggressiveness
    Katz, Ofrat Beyar
    Ben-Tsedek, Neta
    Avivi, Irit
    Alishekevitz, Dror
    Timaner, Michael
    Miller, Valeria
    Lindzen, Moshit
    Yarden, Yosef
    Shaked, Yuval
    BLOOD, 2015, 126 (23)
  • [10] Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
    Piazza, Francesco
    Manni, Sabrina
    Tubi, Laura Quotti
    Montini, Barbara
    Pavan, Laura
    Colpo, Anna
    Gnoato, Marianna
    Cabrelle, Anna
    Adami, Fausto
    Zambello, Renato
    Trentin, Livio
    Gurrieri, Carmela
    Semenzato, Gianpietro
    BMC CANCER, 2010, 10
1234